Guardant Health
GH
#3339
Rank
C$4.91 B
Marketcap
$39.82
Share price
0.07%
Change (1 day)
33.70%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of June 2024 : C$1.44 Billion

According to Guardant Health 's latest financial reports the company has C$1.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$1.55 B12.96%
2022-12-31C$1.37 B15.43%
2021-12-31C$1.18 B-48.06%
2020-12-31C$2.28 B235.17%
2019-12-31C$0.68 B19.64%
2018-12-31C$0.57 B105.1%
2017-12-31C$0.27 B117.37%
2016-12-31C$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.23 B-14.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.16 B-88.36%๐Ÿ‡บ๐Ÿ‡ธ USA